Burkholderia cepacia (B. cepacia) is an opportunistic, Gram negative pathogen which causes infection mainly in immunocompromised population and associated with high rate of morbidity and mortality in cystic fibrosis patients. Aim of the present study was to analyze the impact of biofield treatment on multidrug resistant B. cepacia. Clinical sample of B. cepacia was divided into two groups i.e. control and biofield treated. The analysis was done after 10 days of treatment and compared with control group. Control and treated group were analyzed for susceptibility pattern, MIC value, biochemical studies and biotype number using MicroScan Walk-Away® system. Sensitivity assay results showed a change in pattern from resistant to intermediate in aztreonam, intermediate to resistant in ceftazidime, ciprofloxacin, imipenem, and levofloxacin while sensitive to resistant in meropenem and piperacillin/tazobactam. The biofield treatment showed an alteration in MIC values of aztreonam, ceftazidime, chloramphenicol, ciprofloxacin, imipenem, levofloxacin, meropenem, piperacillin/tazobactam and tetracycline. Biochemical reactions of treated group showed negative reaction in colistin, lysine, and ornithine while positive reactions to acetamide, arginine, and malonate as compared to control. Overall results showed an alteration of 38.9% in susceptibility pattern, 30% in MIC values of tested antimicrobials and 18.2% change in biochemical reaction after biofield treatment. A significant change in biotype number (02063736) was reported with green pigment as special characteristics after biofield treatment as compared to control (05041776) group with yellow pigment. In treated group, a new species was identified as Pseudomonas aeruginosa, as compared to control. Study findings suggest that biofield treatment has a significant effect on the phenotypic character and biotype number of multidrug resistant strain of B. cepacia.
1. Holmes A, Govan J, Goldstein R (1998) Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis 4: 221-227.
2. Burkholder W (1950) Sour skin, a bacterial rot of onion bulbs. Phytopathology 40: 115-117.
3. Thomassen MJ, Demko CA, Klinger JD, Stern RC (1985) Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis 131: 791-796.
4. De Soyza A, Corris PA (2003) Lung transplantation and the Burkholderia cepacia complex. J Heart Lung Transplant 22: 954-958.
5. Singh V (2013) Antimicrobial resistance. Microbial pathogens and strategies for combating them: science, technology and education. Formatex Research Center 1: 291-296.
6. Gibson RL, Burns JL, Ramsey BW (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168: 918-951.
7. Aaron SD, Ferris W, Henry DA, Speert DP, Macdonald NE (2000) Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am J Respir Crit Care Med 161: 1206-1212.
8. Trivedi MK, Bhardwaj Y, Patil S, Shettigar H, Bulbule, A (2009) Impact of an external energy on Enterococcus faecalis [ATCC-51299] in relation to antibiotic susceptibility and biochemical reactions-an experimental study. J Accord Integr Med 5: 119-130.
9. Hasenohrl F (1904) On the theory of radiation in moving bodies. Annalen der Physik 15: 344-370.
10. Einstein A (1905) Does the inertia of a body depend upon its energy-content. Annalen der Physik 18: 639-641.
11. Rubik B (2002) The biofield hypothesis: its biophysical basis and role in medicine. J Altern Complement Med 8: 703-717.
12. Trivedi MK, Tallapragada RR (2008) A transcendental to changing metal powder characteristics. Met Powder Rep 63: 22-28.
13. Dabhade VV, Tallapragada RR, Trivedi MK (2009) Effect of external energy on atomic, crystalline and powder characteristics of antimony and bismuth powders. Bull Mater Sci 32: 471-479.
14. Trivedi MK, Tallapragada RR (2009) Effect of superconsciousness external energy on atomic, crystalline and powder characteristics of carbon allotrope powders. Mater Res Innov 13: 473-480.
15. Shinde V, Sances F, Patil S, Spence A (2012) Impact of biofield treatment on growth and yield of lettuce and tomato. Aust J Basic & App Sci 6: 100-105.
16. Sances F, Flora E, Patil S, Spence A, Shinde V (2013) Impact of biofield Treatment on Ginseng And Organic Blueberry Yield. AGRIVITA J Agri Sci 35: 22-29.
17. Lenssen AW (2013) Biofield and fungicide seed treatment influences on soybean productivity, seed quality and weed community. Agricultural Journal 8: 138-143.
18. Altekar N, Nayak G (2015) Effect of biofield treatment on plant growth and adaptation. J Environ Health Sci 1: 1-9.
19. Trivedi MK, Patil S (2008) Impact of an external energy on Staphylococcus epidermis [ATCC-13518] in relation to antibiotic susceptibility and biochemical reactions-an experimental study. J Accord Integr Med 4: 230-235.
20. Trivedi MK, Patil S (2008) Impact of an external energy on Yersinia enterocolitica [ATCC-23715] in relation to antibiotic susceptibility and biochemical reactions: an experimental study. Internet J Alternat Med 6: 13.
21. Fader RC, Weaver E, Fossett R, Toyras M, Vanderlaan J, et al. (2013) Multilaboratory study of the biomic automated well-reading instrument versus MicroScan WalkAway for reading MicroScan antimicrobial Susceptibility and identification panels. J Clin Microbiol 51: 1548-1554.
22. Lipuma JJ (2005) Update on the Burkholderia cepacia complex. Curr Opin Pulm Med 11: 528-533.
23. Tenover FC (2006) Mechanisms of antimicrobial resistance in bacteria. Am J Med 119: S3-10.
24. He X1, Li S, Kaminskyj SG (2014) Using Aspergillus nidulans to identify antifungal drug resistance mutations. Eukaryot Cell 13: 288-294.
25. Alekshun MN1, Levy SB (2007) Molecular mechanisms of antibacterial multidrug resistance. Cell 128: 1037-1050.
26. Nzula S1, Vandamme P, Govan JR (2002) Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex. J Antimicrob Chemother 50: 265-269.
27. Reik R1, Spilker T, Lipuma JJ (2005) Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J Clin Microbiol 43: 2926-2928.
28. Avgeri SG1, Matthaiou DK, Dimopoulos G, Grammatikos AP, Falagas ME (2009) Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence. Int J Antimicrob Agents 33: 394-404.
29. van Pelt C1, Verduin CM, Goessens WH, Vos MC, Tümmler B, et al. (1999) Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. J Clin Microbiol 37: 2158-2164.
30. Turner JG1, Clark AJ, Gauthier DK, Williams M (1998) The effect of therapeutic touch on pain and anxiety in burn patients. J Adv Nurs 28: 10-20.
31. Koithan M1 (2009) Introducing Complementary and Alternative Therapies. J Nurse Pract 5: 18-20.
32. Lindstrom E, Hansson M, Lundgren E (1998) Analysis of the T cell activation signaling pathway during ELF magnetic field exposure, p56lck and [Ca2+]i-measurements. Bioeletrochem Bioenerg 46: 129-137.
Cite this work
Researchers should cite this work as follows:
Mahendra KT, Shrikant P, Harish S, Mayank G, Jana S (2015) An Effect of Biofield Treatment on Multidrug-resistant Burkholderia cepacia: A Multihost Pathogen. J Trop Dis 3: 167. doi:10.4172/2329-891X.1000167